Logo image of BFRG

BULLFROG AI HOLDINGS INC (BFRG) Stock Fundamental Analysis

NASDAQ:BFRG - Nasdaq - US12021E1091 - Common Stock - Currency: USD

1.71  -0.03 (-1.72%)

After market: 1.78 +0.07 (+4.09%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BFRG. BFRG was compared to 36 industry peers in the Health Care Technology industry. While BFRG seems to be doing ok healthwise, there are quite some concerns on its profitability. BFRG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

BFRG had negative earnings in the past year.
In the past year BFRG has reported a negative cash flow from operations.
In the past 5 years BFRG always reported negative net income.
BFRG had a negative operating cash flow in each of the past 5 years.
BFRG Yearly Net Income VS EBIT VS OCF VS FCFBFRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

BFRG has a Return On Assets of -174.64%. This is amonst the worse of the industry: BFRG underperforms 86.11% of its industry peers.
With a Return On Equity value of -219.80%, BFRG is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -174.64%
ROE -219.8%
ROIC N/A
ROA(3y)-1273.22%
ROA(5y)-2623.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BFRG Yearly ROA, ROE, ROICBFRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -2K -4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BFRG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BFRG Yearly Profit, Operating, Gross MarginsBFRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

5

2. Health

2.1 Basic Checks

BFRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BFRG has more shares outstanding
BFRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BFRG Yearly Shares OutstandingBFRG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
BFRG Yearly Total Debt VS Total AssetsBFRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

BFRG has an Altman-Z score of 0.10. This is a bad value and indicates that BFRG is not financially healthy and even has some risk of bankruptcy.
BFRG has a Altman-Z score of 0.10. This is comparable to the rest of the industry: BFRG outperforms 50.00% of its industry peers.
BFRG has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
BFRG has a Debt to Equity ratio (0.05) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 0.1
ROIC/WACCN/A
WACC10.45%
BFRG Yearly LT Debt VS Equity VS FCFBFRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

2.3 Liquidity

A Current Ratio of 4.86 indicates that BFRG has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.86, BFRG belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
A Quick Ratio of 4.86 indicates that BFRG has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.86, BFRG belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.86
Quick Ratio 4.86
BFRG Yearly Current Assets VS Current LiabilitesBFRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.98% over the past year.
The Revenue for BFRG has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)8.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.89%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BFRG Yearly Revenue VS EstimatesBFRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 20K 40K 60K

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BFRG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BFRG Price Earnings VS Forward Price EarningsBFRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BFRG Per share dataBFRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BFRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BULLFROG AI HOLDINGS INC

NASDAQ:BFRG (6/17/2025, 8:00:01 PM)

After market: 1.78 +0.07 (+4.09%)

1.71

-0.03 (-1.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.5%
Inst Owner Change45.83%
Ins Owners24.88%
Ins Owner Change-2.13%
Market Cap16.11M
AnalystsN/A
Price TargetN/A
Short Float %4.41%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.96
P/tB 4.96
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS0
BVpS0.34
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -174.64%
ROE -219.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1273.22%
ROA(5y)-2623.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.86
Quick Ratio 4.86
Altman-Z 0.1
F-Score2
WACC10.45%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.52%
OCF growth 3YN/A
OCF growth 5YN/A